# ChemPass

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chempass

- Industry: Healthcare IT
- Headquarters: Budapest, Hungary
- Website: www.chempassltd.com
- Total disclosed funding: $0.5M
- Latest round: Seed (Aug 29, 2018)
- Investors on record: 1

## About

ChemPass Ltd. is a company focused on AI-assisted drug discovery, developing innovative platforms that enhance the efficiency of lead discovery and optimization in medicinal chemistry.Founded in 2016 and headquartered in Budapest, Hungary, ChemPass Ltd. specializes in AI-assisted drug discovery solutions. The company has engaged in 2 deals, with its most recent funding round being a Seed round in August 2018, raising EUR 0.130 million from Hiventures. The CEO is Greg Makara.ChemPass offers AI-assisted drug discovery solutions, including the ChemPass AI-assisted Discovery (AID) Platform for identifying patentable leads and the SynSpace platform for dynamic library design. Their services target pharmaceutical and biotechnology firms, enabling efficient drug development and optimization, while maintaining cost-effectiveness.In the most recent year of 2023, ChemPass reported a revenue of EUR 437,293.30 and an EBITDA of EUR 137,770.90, primarily generated through B2B transactions with clients in the pharmaceutical and biotech sectors.ChemPass plans to utilize its recent Seed funding from August 2018 to enhance its product offerings and expand into new geographic regions. Future product development initiatives are underway, with specific launches to be announced. The company is targeting increased presence in European and global markets, aligning with its strategic growth objectives.

## Funding rounds

- Seed, Aug 29, 2018, $0.1M — Hiventures
- Seed, Sep 12, 2017, $0.3M — Hiventures

## Investors

- Hiventures (https://capitalatlas.ai/funds/hiventures) — Seed